stoxline Quote Chart Rank Option Currency Glossary
PetIQ, Inc. (PETQ)
16.28  0.25 (1.56%)    04-19 16:00
Open: 15.95
High: 16.41
Volume: 147,964
Pre. Close: 16.03
Low: 15.95
Market Cap: 475(M)
Technical analysis
2024-04-19 5:11:34 PM
Short term     
Mid term     
Targets 6-month :  20.56 1-year :  22.37
Resists First :  17.6 Second :  19.15
Pivot price 17.39
Supports First :  15.09 Second :  12.55
MAs MA(5) :  16.12 MA(20) :  17.46
MA(100) :  17.9 MA(250) :  17.28
MACD MACD :  -0.4 Signal :  -0.2
%K %D K(14,3) :  9.6 D(3) :  8.3
RSI RSI(14): 39.1
52-week High :  22.97 Low :  11.26
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ PETQ ] has closed above bottom band by 23.4%. Bollinger Bands are 83.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 16.43 - 16.5 16.5 - 16.56
Low: 15.79 - 15.86 15.86 - 15.93
Close: 16.16 - 16.28 16.28 - 16.39
Company Description

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.

Headline News

Sat, 20 Apr 2024
PetIQ Stock: Guidance And Street Estimates Are Too Conservative (NASDAQ:PETQ) - Seeking Alpha

Fri, 19 Apr 2024
Should You Be Concerned About PetIQ, Inc.'s (NASDAQ:PETQ) ROE? - Yahoo Movies UK

Thu, 18 Apr 2024
DekaBank Deutsche Girozentrale Takes Position in PetIQ, Inc. (NASDAQ:PETQ) - Defense World

Mon, 15 Apr 2024
Wall Street Analysts Think PetIQ (PETQ) Could Surge 76.18%: Read This Before Placing a Bet - Yahoo Finance

Sun, 14 Apr 2024
PetIQ, Inc. (NASDAQ:PETQ) Shares Purchased by SG Americas Securities LLC - Defense World

Sat, 13 Apr 2024
PetIQ (NASDAQ:PETQ) Seems To Use Debt Quite Sensibly - Simply Wall St

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Drug Manufacturers - Specialty & Generic
Shares Out 29 (M)
Shares Float 26 (M)
Held by Insiders 7 (%)
Held by Institutions 100.3 (%)
Shares Short 1,750 (K)
Shares Short P.Month 1,790 (K)
Stock Financials
EPS 0.07
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.57
Profit Margin 0.1 %
Operating Margin -0.6 %
Return on Assets (ttm) 4 %
Return on Equity (ttm) 1.1 %
Qtrly Rev. Growth 19.5 %
Gross Profit (p.s.) 0
Sales Per Share 37.67
EBITDA (p.s.) 3.09
Qtrly Earnings Growth 0 %
Operating Cash Flow 62 (M)
Levered Free Cash Flow 40 (M)
Stock Valuations
PE Ratio 232.57
PEG Ratio 0.5
Price to Book value 2.14
Price to Sales 0.43
Price to Cash Flow 7.68
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android